SYFOVRE (pegcetacoplan/PF)
OPHTHALMIC - MACULAR DEGENERATION AGENTS·NONEXUDATIVE AGE-RELATED MACULAR DEGENERATION
Apellis Pharmaceuticals
Indication
Nonexudative age-related macular degeneration
Nonexudative age-related macular degeneration, commonly termed dry or non-neovascular age-related macular degeneration, is a chronic, progressive neurodegenerative disorder of the central retina that predominantly affects older adults. Read more about Nonexudative age-related macular degeneration
3 drugs 3 manufacturers
Drugs that treat it
Common Nonexudative age-related macular degeneration therapies.
IZERVAY (avacincaptad pegol sodium/PF)
NONEXUDATIVE AGE-RELATED MACULAR DEGENERATION
IVERIC BIO INC
IZERVAY (avacincaptad pegol sodium/PF)
OPHTHALMIC - MACULAR DEGENERATION AGENTS·NONEXUDATIVE AGE-RELATED MACULAR DEGENERATION
Astellas Pharma US
Filter & compare in the drug finder →Opens the drug finder with Nonexudative age-related macular degeneration preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonNonexudative age-related macular degeneration, commonly termed dry or non-neovascular age-related macular degeneration, is a chronic, progressive neurodegenerative disorder of the central retina that predominantly affects older adults.
It is pathologically characterized by the accumulation of extracellular lipid- and protein-rich deposits, known as drusen, between the retinal pigment epithelium and Bruch membrane.
This process leads to progressive retinal pigment epithelium dysfunction, photoreceptor loss, and pigmentary abnormalities within the macula in the absence of exudation, choroidal neovascularization, or subretinal fluid leakage.
In its advanced stages, it manifests as geographic atrophy, resulting in gradual, irreversible impairment of fine, high-acuity central vision.
- nih.gov
Nonexudative age-related macular degeneration, commonly termed dry or non-neovascular age-related macular degeneration, is a chronic, progressive neurodegenerative disorder of the central retina that predominantly affects older adults
- nih.gov
Nonexudative age-related macular degeneration, commonly termed dry or non-neovascular age-related macular degeneration, is a chronic, progressive neurodegenerative disorder of the central retina that predominantly affects older adults It is pathologically characterized by the accumulation of extracellular lipid- and protein-rich deposits, known as drusen, between the retinal pigment epithelium and Bruch membrane This process leads to progressive retinal pigment epithelium dysfunction, photorecep...
- ubiehealth.com
Nonexudative age-related macular degeneration, commonly termed dry or non-neovascular age-related macular degeneration, is a chronic, progressive neurodegenerative disorder of the central retina that predominantly affects older adults
- opted.org
It is pathologically characterized by the accumulation of extracellular lipid- and protein-rich deposits, known as drusen, between the retinal pigment epithelium and Bruch membrane In its advanced stages, it manifests as geographic atrophy, resulting in gradual, irreversible impairment of fine, high-acuity central vision
Personalize your experience
Follow Nonexudative age-related macular degeneration and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.